| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/26/2011 | CA2353554C Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 04/21/2011 | WO2011047320A2 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | WO2011047319A2 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | WO2011047119A1 Compounds for the treatment of hepatitis c |
| 04/21/2011 | WO2011046970A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon |
| 04/21/2011 | WO2011046964A2 Inhibitors of bruton's tyrosine kinase |
| 04/21/2011 | WO2011046946A2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 04/21/2011 | WO2011046916A1 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/21/2011 | WO2011045702A1 Pyrrolo[2,3-d] pyrimidine compounds |
| 04/21/2011 | WO2011045344A1 Pyrazolopyridine derivatives as anticancer agent |
| 04/21/2011 | WO2011017347A3 Mesoionic pesticides |
| 04/21/2011 | WO2010150281A3 Novel azabicyclohexanes |
| 04/21/2011 | US20110092695 Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance |
| 04/21/2011 | US20110092520 Process for producing bicycloaniline derivatives |
| 04/21/2011 | US20110092505 Organic compounds |
| 04/21/2011 | US20110092498 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as met kinase inhibitors |
| 04/21/2011 | US20110092497 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092459 Alpha helix mimetics and methods relating thereto |
| 04/21/2011 | US20110092368 2,4,6-Phenyl-substituted cyclic ketoenols |
| 04/21/2011 | US20110091373 Paa nanoparticles for enhancement of tumor imaging |
| 04/21/2011 | DE102009049679A1 Pyrazolopyrimidinderivate Pyrazolopyrimidinderivate |
| 04/21/2011 | CA2777762A1 Amino - pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilon |
| 04/21/2011 | CA2777739A1 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | CA2777734A1 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | CA2777563A1 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/21/2011 | CA2776543A1 Inhibitors of bruton's tyrosine kinase |
| 04/21/2011 | CA2776028A1 Pyrrolo[2,3-d]pyrimidine compounds |
| 04/21/2011 | CA2773604A1 Herbicidal compounds |
| 04/20/2011 | EP2311838A1 Crystalline form of pemetrexed diacid and process for the preparation thereof |
| 04/20/2011 | EP2311830A1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 04/20/2011 | EP2311814A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents |
| 04/20/2011 | EP2311807A1 Compounds and composition as protein kinase inhibitors |
| 04/20/2011 | EP2311806A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 04/20/2011 | EP2310392A2 Tricyclic antagonists of prostaglandin d2 receptors |
| 04/20/2011 | EP2310375A1 Chemical compounds |
| 04/20/2011 | EP2310019A2 5-ht3 receptor modulators, methods of making, and use thereof |
| 04/20/2011 | EP2310014A1 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 04/20/2011 | EP2310013A1 Bicyclic triazole derivatives for treating tumors |
| 04/20/2011 | EP1976853B1 Novel compounds and use thereof |
| 04/20/2011 | EP1919922B1 Method for synthesizing spiro quaternary ammonium systems |
| 04/20/2011 | EP1781662B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
| 04/20/2011 | CN102027000A Method for producing bicyclic guanidines by use of a cyclic thiourea |
| 04/20/2011 | CN102026999A Azetidine and cyclobutane derivatives as JAK inhibitors |
| 04/20/2011 | CN102026990A Novel inhibitors of hepatitis c virus replication |
| 04/20/2011 | CN102026983A Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs |
| 04/20/2011 | CN102026972A New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 04/20/2011 | CN102026913A Fluoride processing method |
| 04/20/2011 | CN102026641A Pharmaceutical preparation comprising DPP-IV inhibitor and other diabetes therapeutic agent in concomitant or combined form |
| 04/20/2011 | CN102026637A Lipoprotein lipase-activating compositions comprising benzene derivates |
| 04/20/2011 | CN102020697A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 04/20/2011 | CN102020650A Method for preparing 2-nitro-5,10,15,20 metal tetraphenyl porphyrin |
| 04/20/2011 | CN102020649A Diketopiperazine compound as well as composition, preparation method and application thereof |
| 04/20/2011 | CN102020648A 3-aryl-6-aryl-[1,2,4] triazol [4,3-b] pyridazine taken as cell proliferation inhibitor and application of cell proliferation inhibitor |
| 04/20/2011 | CN102020647A Preparation method of 1-(2,2-difluoroethoxy)-6-trifluoromethyl-N-([1,2,4]triazolezol[1,5-C] pyrimidine-2-)benzsulfamide |
| 04/20/2011 | CN102020646A Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 04/20/2011 | CN102020645A Pyrazolopyrimidinone derivatives and pharmaceutical salts, preparation method and application thereof |
| 04/20/2011 | CN102020644A Method for preparing 5,7-dihydroxy-6-sulfoguanyl-s-triazole[2,3-a]bipyrimidine |
| 04/20/2011 | CN101570538B Preparation method of sitagliptin intermediate |
| 04/20/2011 | CN101362764B 5,7-diaminopyrazolo '4,3-d!pyrimidines with PDE-5 inhibiting activity |
| 04/19/2011 | US7928237 Fused ring azadecalin glucocorticoid receptor modulators |
| 04/19/2011 | US7928224 Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same |
| 04/19/2011 | US7928222 Porphyrin compound, process for producing porphyrin compound, three-dimensional optical recording material, and three-dimensional optical recording medium |
| 04/19/2011 | US7928221 Compound and method of producing organic semiconductor device |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | US7928106 Aza-pyridopyrimidinone derivatives |
| 04/19/2011 | US7928101 Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof |
| 04/19/2011 | US7928099 Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists |
| 04/19/2011 | US7927623 Pleasant taste; bioabsorbable; overcoated water insoluble drug in alcohol solvent and water soluble binder; mixing, compression |
| 04/19/2011 | CA2539476C Quinazoline potassium channel inhibitors |
| 04/19/2011 | CA2513081C Pyrrolopyridazine derivatives |
| 04/19/2011 | CA2498851C Heterocyclocarboxamide derivatives |
| 04/19/2011 | CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents |
| 04/14/2011 | WO2011044481A1 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 04/14/2011 | WO2011043479A1 Therapeutic agent for cerebral infarction |
| 04/14/2011 | WO2011043369A1 Water-soluble porphyrin and process for production thereof |
| 04/14/2011 | WO2011042798A1 Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer |
| 04/14/2011 | WO2011042550A1 [18 f] - labelled analogues of flumazenil as in vivo imaging agents |
| 04/14/2011 | WO2011042529A1 Automated radiosynthesis |
| 04/14/2011 | WO2011042497A1 Pyrrolo [3,2 -e] [1,2,4] triazolo [1,5-a] pyrimidines derivatives as inhibitors of microglia activation |
| 04/14/2011 | WO2011042496A1 Pyrrolo [3, 2 -e] [1,2,4] triazolo [1,5 -a] pyrimidines derivatives as inhibitors of microglia activation |
| 04/14/2011 | WO2011042399A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists |
| 04/14/2011 | WO2011042389A2 Phenylpyri(mi)dinylazoles |
| 04/14/2011 | WO2011042107A2 Materials for organic electroluminescent devices |
| 04/14/2011 | WO2011016016A9 Processes for the preparation of vardenafil |
| 04/14/2011 | US20110087022 Dipeptidyl Peptidase Inhibitors |
| 04/14/2011 | US20110087021 Novel preparation process |
| 04/14/2011 | US20110086898 Pyrazolooxazole compound |
| 04/14/2011 | US20110086866 Inhibitors of bruton's tyrosine kinase |
| 04/14/2011 | US20110086860 Compound |
| 04/14/2011 | US20110086859 Alkyl substituted indoloquinoxalines |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086851 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086810 HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d] PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| 04/14/2011 | US20110083984 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis |
| 04/14/2011 | CA2784277A1 Pyrazoles derivatives modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 04/14/2011 | CA2777114A1 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 04/14/2011 | CA2776884A1 Materials for organic electroluminescent devices |